Polyvalent vaccine-KLH conjugate and OPT-821 with bevacizumab (BEV) in patients with ovarian cancer in second or greater remission Meeting Abstract
| Authors: | O'Cearbhaill, R. E.; Iasonos, A.; Zhou, Q.; Durany, R.; Aghajanian, C.; Hensley, M. L.; Konner, J. A.; Makker, V.; Tew, W. P.; Fleisher, M.; Sabbatini, P. |
| Abstract Title: | Polyvalent vaccine-KLH conjugate and OPT-821 with bevacizumab (BEV) in patients with ovarian cancer in second or greater remission |
| Meeting Title: | 49th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 31 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2013 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2013-05-20 |
| Language: | English |
| ACCESSION: | WOS:000335419602064 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2013.31.15_suppl.5550 |
| Notes: | Meeting Abstract: 5550 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
